Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Cervera

Showing results (251-260 of 412) with videos related to

Pageof 42
Sort By:
The Israel Medical Association Journal : IMAJ|September 20, 2007
Preventing death in the catastrophic antiphospholipid (Asherson) syndromeMario García-Carrasco, Ricardo O Escárcega, Claudia Mendoza-Pinto, et al.
Autoimmunity Reviews|September 1, 2010
The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosusClaudio Galarza-Maldonado, María R Kourilovitch, Julio E Molineros, et al.
Arthritis Research & Therapy|April 28, 2022
Systemic sclerosis and pregnancy outcomes: a retrospective study from a single centerGiuseppe Barilaro, Aleida Castellanos, Inês Gomez-Ferreira, et al.
Medicine|March 18, 2003
Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patientsGerard Espinosa, Eugénia Santos, Ricard Cervera, et al.
Rheumatology (Oxford, England)|March 11, 2005
Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndromeSònia Jiménez, M Angels García-Criado, Dolors Tàssies, et al.
British Journal of Haematology|March 12, 2002
True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activityTeresa Gallart, Carmen Benito, Joan-Carles Reverter, et al.
Autoimmunity Reviews|October 13, 2009
Factors influencing polyautoimmunity in systemic lupus erythematosusAdriana Rojas-Villarraga, Carlos-Enrique Toro, Gerard Espinosa, et al.
Autoimmunity Reviews|August 12, 2008
Treatment of Raynaud's phenomenonMario García-Carrasco, Mario Jiménez-Hernández, Ricardo O Escárcega, et al.
Immunologic Research|April 5, 2013
Toxoplasma gondii: bystander or cofactor in rheumatoid arthritisSvetlana Fischer, Nancy Agmon-Levin, Yinon Shapira, et al.
Autoimmunity Reviews|November 28, 2008
Use of rituximab in patients with systemic lupus erythematosus: an updateMario García-Carrasco, Mario Jiménez-Hernández, Ricardo O Escárcega, et al.
Pageof 42

Showing results (251-260 of 412) with videos related to

Sort By:
Pageof 42
The Israel Medical Association Journal : IMAJ|September 20, 2007
Preventing death in the catastrophic antiphospholipid (Asherson) syndromeMario García-Carrasco, Ricardo O Escárcega, Claudia Mendoza-Pinto, et al.
Autoimmunity Reviews|September 1, 2010
The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosusClaudio Galarza-Maldonado, María R Kourilovitch, Julio E Molineros, et al.
Arthritis Research & Therapy|April 28, 2022
Systemic sclerosis and pregnancy outcomes: a retrospective study from a single centerGiuseppe Barilaro, Aleida Castellanos, Inês Gomez-Ferreira, et al.
Medicine|March 18, 2003
Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patientsGerard Espinosa, Eugénia Santos, Ricard Cervera, et al.
Rheumatology (Oxford, England)|March 11, 2005
Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndromeSònia Jiménez, M Angels García-Criado, Dolors Tàssies, et al.
British Journal of Haematology|March 12, 2002
True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activityTeresa Gallart, Carmen Benito, Joan-Carles Reverter, et al.
Autoimmunity Reviews|October 13, 2009
Factors influencing polyautoimmunity in systemic lupus erythematosusAdriana Rojas-Villarraga, Carlos-Enrique Toro, Gerard Espinosa, et al.
Autoimmunity Reviews|August 12, 2008
Treatment of Raynaud's phenomenonMario García-Carrasco, Mario Jiménez-Hernández, Ricardo O Escárcega, et al.
Immunologic Research|April 5, 2013
Toxoplasma gondii: bystander or cofactor in rheumatoid arthritisSvetlana Fischer, Nancy Agmon-Levin, Yinon Shapira, et al.
Autoimmunity Reviews|November 28, 2008
Use of rituximab in patients with systemic lupus erythematosus: an updateMario García-Carrasco, Mario Jiménez-Hernández, Ricardo O Escárcega, et al.
Pageof 42